Ping Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ping Lv has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Haitao Shen
Lab of Pathology, Hebei Medical University, Shijiazhuang, China
5 shared publications Shengnan Wang
Department of Pharmacology The Key Laboratory of Neural and Vascular Biology Ministry of Education The Key Laboratory of New Drug Pharmacology and Toxicology The Hebei Collaboration Innovation Center for Mechanism Diagnosis and Treatment of Neurological and Psychiatric Disease Hebei Medical University Shijiazhuang Hebei 050017 China
5 shared publicationsFei Wang
Department of Pharmacology The Key Laboratory of Neural and Vascular Biology Ministry of Education The Key Laboratory of New Drug Pharmacology and Toxicology The Hebei Collaboration Innovation Center for Mechanism Diagnosis and Treatment of Neurological and Psychiatric Disease Hebei Medical University Shijiazhuang Hebei 050017 China
4 shared publicationsHaitao Shen
Lab of Pathology, Hebei Medical University
4 shared publicationsJiaxi Liu
Department of Pharmacology, The Key Laboratory of Neural and Vascular Biology, Ministry of Education, The Key Laboratory of New Drug Pharmacology and Toxicology, The Hebei Collaboration Innovation Center for Mechanism, Diagnosis and Treatment of Neurological and Psychiatric Disease, Hebei Medical University, Shijiazhuang, China
4 shared publicationsMingshun Lu
Department of Pharmacology, The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Medical University
4 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
CXCR2 deficiency impairs auditory function in spiral ganglion neurons by altering excitability
CXC chemokine receptor 2 (CXCR2), a key member of the chemokine receptor family, plays a central role in regulating immune and inflammatory responses. Inflammation has been established as a critical pathological factor in various auditory disorders, including noise-induced hearing loss, drug-induced ototoxicity, and age-related hearing loss; however, the expression patterns and biological functions of CXCR2 in key cells involved in auditory signal transduction remain unclear. Here, we demonstrated that CXCR2 is abundantly expressed in cochlear spiral ganglion neurons (SGNs), hair cells, and the stria vascularis. Genetic deletion of CXCR2 resulted in progressive hearing loss in mice. SGNs from CXCR2 knockout mice exhibited increased expression of the Kv1.2 potassium channel, impaired ribbon synapses, and altered myelin integrity. Electrophysiological analysis revealed enhanced Kv1 currents and significantly reduced excitability in CXCR2-deficient SGNs. Notably, CXCR2 knockdown in SGNs using an adeno-associated virus recapitulated the hearing loss phenotype. In conclusion, our findings revealed that CXCR2 is essential for hearing as it regulates SGN excitability.
- 15 October 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
Open AccessCXCR2 deficiency impairs auditory function in spiral ganglion neurons by altering excitability
CXC chemokine receptor 2 (CXCR2), a key member of the chemokine receptor family, plays a central role in regulating immune and inflammatory responses. Inflammation has been established as a critical pathological factor in various auditory disorders, including noise-induced hearing loss, drug-induced ototoxicity, and age-related hearing loss; however, the expression patterns and biological functions of CXCR2 in key cells involved in auditory signal transduction remain unclear. Here, we demonstrated that CXCR2 is abundantly expressed in cochlear spiral ganglion neurons (SGNs), hair cells, and the stria vascularis. Genetic deletion of CXCR2 resulted in progressive hearing loss in mice. SGNs from CXCR2 knockout mice exhibited increased expression of the Kv1.2 potassium channel, impaired ribbon synapses, and altered myelin integrity. Electrophysiological analysis revealed enhanced Kv1 currents and significantly reduced excitability in CXCR2-deficient SGNs. Notably, CXCR2 knockdown in SGNs using an adeno-associated virus recapitulated the hearing loss phenotype. In conclusion, our findings revealed that CXCR2 is essential for hearing as it regulates SGN excitability.
- 23 June 2026
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 24, 1-20
NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics, Subtype Selectivity, and Signaling Pathways
Ischemic stroke remains a leading cause of death and disability worldwide, yet therapeutic options beyond thrombolysis are limited. A central paradox in stroke neuropharmacology lies in why complete NMDA receptor (NMDAR) blockade has repeatedly failed in clinical trials, while more tar-geted interventions retain therapeutic promise. To address this paradox, we propose a “Spatiotemporal-Subtype-Signaling (3S)” framework that integrates three interrelated dimensions: (1) spatiotemporal dynamics, in which receptor expression, phosphorylation, and subcellular localization shift across the transition from acute energy failure to delayed neurodegeneration; (2) subtype selectivity, in which dis-tinct NMDAR subtypes exert opposing effects on neuronal fate, with GluN2A promoting survival via the PI3K-Akt-FOXO/GSK3β and ERK-CREB-BDNF pathways, GluN2B mediating excitotoxicity through p38 MAPK, JNK, and PSD-95-nNOS coupling, and GluN2C/GluN2D contributing through context-dependent mechanisms; and (3) signaling pathway selectivity, defined by the differential coupling of receptor subtypes to pro-survival versus pro-death cascades. Recent work further high-lights NMDAR-ferroptosis crosstalk and sexual dimorphism: males rely predominantly on non-ionotropic GluN2B signaling, whereas females depend on estrogen receptor α (ERα) and G protein-coupled receptor 30 (GPR30)-mediated pathways. Translational efforts include subtype-selective antagonists (e.g., NP10679, a pH-sensitive GluN2B inhibitor) and disruptors of pathological protein-protein interactions (e.g., nerinetide, which targets the PSD-95-nNOS interface), while remote ischem-ic postconditioning has shown encouraging clinical results. Although these mechanisms remain primarily supported by preclinical evidence, they extend the scope of the framework. Collectively, the 3S framework clarifies why complete receptor blockade fails while precision interventions may succeed, and identifies priorities for sex-specific, subtype-targeted neuroprotective strategies in ischemic stroke.
- 23 June 2026
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 24, 1-20
NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics, Subtype Selectivity, and Signaling Pathways
Ischemic stroke remains a leading cause of death and disability worldwide, yet therapeutic options beyond thrombolysis are limited. A central paradox in stroke neuropharmacology lies in why complete NMDA receptor (NMDAR) blockade has repeatedly failed in clinical trials, while more tar-geted interventions retain therapeutic promise. To address this paradox, we propose a “Spatiotemporal-Subtype-Signaling (3S)” framework that integrates three interrelated dimensions: (1) spatiotemporal dynamics, in which receptor expression, phosphorylation, and subcellular localization shift across the transition from acute energy failure to delayed neurodegeneration; (2) subtype selectivity, in which dis-tinct NMDAR subtypes exert opposing effects on neuronal fate, with GluN2A promoting survival via the PI3K-Akt-FOXO/GSK3β and ERK-CREB-BDNF pathways, GluN2B mediating excitotoxicity through p38 MAPK, JNK, and PSD-95-nNOS coupling, and GluN2C/GluN2D contributing through context-dependent mechanisms; and (3) signaling pathway selectivity, defined by the differential coupling of receptor subtypes to pro-survival versus pro-death cascades. Recent work further high-lights NMDAR-ferroptosis crosstalk and sexual dimorphism: males rely predominantly on non-ionotropic GluN2B signaling, whereas females depend on estrogen receptor α (ERα) and G protein-coupled receptor 30 (GPR30)-mediated pathways. Translational efforts include subtype-selective antagonists (e.g., NP10679, a pH-sensitive GluN2B inhibitor) and disruptors of pathological protein-protein interactions (e.g., nerinetide, which targets the PSD-95-nNOS interface), while remote ischem-ic postconditioning has shown encouraging clinical results. Although these mechanisms remain primarily supported by preclinical evidence, they extend the scope of the framework. Collectively, the 3S framework clarifies why complete receptor blockade fails while precision interventions may succeed, and identifies priorities for sex-specific, subtype-targeted neuroprotective strategies in ischemic stroke.
- Open Access
- 11 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (41) , e10477
LRRC8A Regulates Outer Hair Cell Volume and Electromotility and is Required for Hearing
Damage to the cochlear outer hair cell (OHC) is a major cause of deafness in mammals. OHCs amplify the auditory signals to enhance the sensitivity and sound frequency selectivity of the auditory system. However, detailed mechanisms underlying functional OHC regulation remain unclear. Here, it is demonstrated that volume‐regulated anion channels (VRACs) are essential for OHC function. VRAC subunits are highly expressed in OHCs. Genetic deletion of leucin‐rich repeat containing 8A (LRRC8A), the obligatory VRAC subunit, in hair cells results in hearing loss, whereas re‐expressing LRRC8A in the cochlea restores hearing in LRRC8A‐deficient mice. By employing patch‐clamp electrophysiology, it is shown that VRAC in OHCs is activated by hypotonicity and is involved in regulating cell volume. Furthermore, the nonlinear capacitance (NLC), a measure of electromotility, is decreased in the OHCs from LRRC8A‐deficient mice. Therefore, LRRC8A deficiency compromises electromotility of OHCs and impairs signal amplification. In conclusion, the findings highlight the essential role of VRAC in OHC electromotility and its necessity for auditory function.
- 11 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (41) , e10477
Open AccessLRRC8A Regulates Outer Hair Cell Volume and Electromotility and is Required for Hearing
Damage to the cochlear outer hair cell (OHC) is a major cause of deafness in mammals. OHCs amplify the auditory signals to enhance the sensitivity and sound frequency selectivity of the auditory system. However, detailed mechanisms underlying functional OHC regulation remain unclear. Here, it is demonstrated that volume‐regulated anion channels (VRACs) are essential for OHC function. VRAC subunits are highly expressed in OHCs. Genetic deletion of leucin‐rich repeat containing 8A (LRRC8A), the obligatory VRAC subunit, in hair cells results in hearing loss, whereas re‐expressing LRRC8A in the cochlea restores hearing in LRRC8A‐deficient mice. By employing patch‐clamp electrophysiology, it is shown that VRAC in OHCs is activated by hypotonicity and is involved in regulating cell volume. Furthermore, the nonlinear capacitance (NLC), a measure of electromotility, is decreased in the OHCs from LRRC8A‐deficient mice. Therefore, LRRC8A deficiency compromises electromotility of OHCs and impairs signal amplification. In conclusion, the findings highlight the essential role of VRAC in OHC electromotility and its necessity for auditory function.
- Open Access
- 15 August 2024
- Published by Wiley in Aging Cell
- Vol. 23 (12) , e14305
Upregulation of the Cav1.3 channel in inner hair cells by interleukin 6‐dependent inflammaging contributes to age‐related hearing loss
Age‐related hearing loss (AHL) is the most common sensory disorder amongst the older population. Inflammaging is a ≈chronic low‐grade inflammation that worsens with age and is an early sign of AHL; however, the underlying mechanisms remain unclear. We used electrophysiological and genetic approaches to establish the importance of interleukin 6 (IL‐6)‐dependent inflammation in AHL. Elevated IL‐6 in the cochlea enhanced Cav1.3 calcium channel function in the inner hair cell (IHC) synapse in mice with AHL. IL‐6 upregulated the Cav1.3 channel via the Janus kinase‐mitogen activated kinase pathway, causing neurotransmitter excitotoxicity and synapse impairment; IL‐6 deficiency or the administration of a Cav1.3 channel blocker attenuated this age‐related damage, and rescued hearing loss. Thus, IL‐6‐dependent inflammaging upregulated the Cav1.3 channel in IHCs, contributing to AHL. Our findings could help the comprehensive understanding of inflammaging's effects on AHL, aiding in early intervention to protect against hearing decline.
- 15 August 2024
- Published by Wiley in Aging Cell
- Vol. 23 (12) , e14305
Open AccessUpregulation of the Cav1.3 channel in inner hair cells by interleukin 6‐dependent inflammaging contributes to age‐related hearing loss
Age‐related hearing loss (AHL) is the most common sensory disorder amongst the older population. Inflammaging is a ≈chronic low‐grade inflammation that worsens with age and is an early sign of AHL; however, the underlying mechanisms remain unclear. We used electrophysiological and genetic approaches to establish the importance of interleukin 6 (IL‐6)‐dependent inflammation in AHL. Elevated IL‐6 in the cochlea enhanced Cav1.3 calcium channel function in the inner hair cell (IHC) synapse in mice with AHL. IL‐6 upregulated the Cav1.3 channel via the Janus kinase‐mitogen activated kinase pathway, causing neurotransmitter excitotoxicity and synapse impairment; IL‐6 deficiency or the administration of a Cav1.3 channel blocker attenuated this age‐related damage, and rescued hearing loss. Thus, IL‐6‐dependent inflammaging upregulated the Cav1.3 channel in IHCs, contributing to AHL. Our findings could help the comprehensive understanding of inflammaging's effects on AHL, aiding in early intervention to protect against hearing decline.
- Open Access
- 20 September 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Repressor element 1-silencing transcription factor deficiency yields profound hearing loss through Kv7.4 channel upsurge in auditory neurons and hair cells
Repressor element 1-silencing transcription factor (REST) is a transcriptional repressor that recognizes neuron-restrictive silencer elements in the mammalian genomes in a tissue- and cell-specific manner. The identity of REST target genes and molecular details of how REST regulates them are emerging. We performed conditional null deletion of Rest (cKO), mainly restricted to murine hair cells (HCs) and auditory neurons (aka spiral ganglion neurons [SGNs]). Null inactivation of full-length REST did not affect the development of normal HCs and SGNs but manifested as progressive hearing loss in adult mice. We found that the inactivation of REST resulted in an increased abundance of Kv7.4 channels at the transcript, protein, and functional levels. Specifically, we found that SGNs and HCs from Rest cKO mice displayed increased Kv7.4 expression and augmented Kv7 currents; SGN’s excitability was also significantly reduced. Administration of a compound with Kv7.4 channel activator activity, fasudil, recapitulated progressive hearing loss in mice. In contrast, inhibition of the Kv7 channels by XE991 rescued the auditory phenotype of Rest cKO mice. Previous studies identified some loss-of-function mutations within the Kv7.4-coding gene, Kcnq4, as a causative factor for progressive hearing loss in mice and humans. Thus, the findings reveal that a critical homeostatic Kv7.4 channel level is required for proper auditory functions.
- 20 September 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessRepressor element 1-silencing transcription factor deficiency yields profound hearing loss through Kv7.4 channel upsurge in auditory neurons and hair cells
Repressor element 1-silencing transcription factor (REST) is a transcriptional repressor that recognizes neuron-restrictive silencer elements in the mammalian genomes in a tissue- and cell-specific manner. The identity of REST target genes and molecular details of how REST regulates them are emerging. We performed conditional null deletion of Rest (cKO), mainly restricted to murine hair cells (HCs) and auditory neurons (aka spiral ganglion neurons [SGNs]). Null inactivation of full-length REST did not affect the development of normal HCs and SGNs but manifested as progressive hearing loss in adult mice. We found that the inactivation of REST resulted in an increased abundance of Kv7.4 channels at the transcript, protein, and functional levels. Specifically, we found that SGNs and HCs from Rest cKO mice displayed increased Kv7.4 expression and augmented Kv7 currents; SGN’s excitability was also significantly reduced. Administration of a compound with Kv7.4 channel activator activity, fasudil, recapitulated progressive hearing loss in mice. In contrast, inhibition of the Kv7 channels by XE991 rescued the auditory phenotype of Rest cKO mice. Previous studies identified some loss-of-function mutations within the Kv7.4-coding gene, Kcnq4, as a causative factor for progressive hearing loss in mice and humans. Thus, the findings reveal that a critical homeostatic Kv7.4 channel level is required for proper auditory functions.
- Open Access
- 13 April 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (4) , 1-14
Downregulation of REST in the cochlea contributes to age-related hearing loss via the p53 apoptosis pathway
Age-related hearing loss (AHL) is the most common sensory disorder amongst the elderly population. Although the degeneration of spiral ganglion neurons (SGNs) and hair cells (HCs) is considered to play a critical role in AHL, the mechanism has not been fully outlined. The repressor element 1-silencing transcription factor (REST) has recently been associated with mediating cell death in neurodegenerative diseases. However, whether REST induces degeneration of cochlear HCs and SGNs to contribute to AHL remains unknown. Here, we report that REST expression was decreased in HCs and SGNs in AHL mice. Conditional deletion ofRestin HCs and SGNs of 2-month-old mice resulted in hearing loss accompanied by the upregulation of p53, TNFR1(tumor necrosis factor receptor-1), and cleaved caspase-3. The p53 inhibitor pifithrin-α significantly attenuated SGN and HC damage and rescued hearing impairment inRestcKO mice. Furthermore, downregulation of REST by H2O2treatment induced apoptosis in the House Ear Institute Organ of Corti 1 cell, through the upregulation of p53. In contrast, overexpression of REST reversed the changes in p53 expression. In addition, REST was further shown to bind directly to the p53 promoter site, thereby inhibiting the effect of p53. Finally, in aged mice, the p53 inhibitor significantly reduced loss of HCs and SGNs, and subsequently improved hearing. In summary, our findings indicate that REST has a protective role in AHL, and that its deficiency upregulates p53 and induces cochlear cell apoptosis, which that leads to deafness.
- 13 April 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (4) , 1-14
Open AccessDownregulation of REST in the cochlea contributes to age-related hearing loss via the p53 apoptosis pathway
Age-related hearing loss (AHL) is the most common sensory disorder amongst the elderly population. Although the degeneration of spiral ganglion neurons (SGNs) and hair cells (HCs) is considered to play a critical role in AHL, the mechanism has not been fully outlined. The repressor element 1-silencing transcription factor (REST) has recently been associated with mediating cell death in neurodegenerative diseases. However, whether REST induces degeneration of cochlear HCs and SGNs to contribute to AHL remains unknown. Here, we report that REST expression was decreased in HCs and SGNs in AHL mice. Conditional deletion ofRestin HCs and SGNs of 2-month-old mice resulted in hearing loss accompanied by the upregulation of p53, TNFR1(tumor necrosis factor receptor-1), and cleaved caspase-3. The p53 inhibitor pifithrin-α significantly attenuated SGN and HC damage and rescued hearing impairment inRestcKO mice. Furthermore, downregulation of REST by H2O2treatment induced apoptosis in the House Ear Institute Organ of Corti 1 cell, through the upregulation of p53. In contrast, overexpression of REST reversed the changes in p53 expression. In addition, REST was further shown to bind directly to the p53 promoter site, thereby inhibiting the effect of p53. Finally, in aged mice, the p53 inhibitor significantly reduced loss of HCs and SGNs, and subsequently improved hearing. In summary, our findings indicate that REST has a protective role in AHL, and that its deficiency upregulates p53 and induces cochlear cell apoptosis, which that leads to deafness.
- 1 August 2021
- Published by Elsevier in Experimental Gerontology
- Vol. 151, 111429
Association between Cav3 channel upregulation in spiral ganglion neurons and age-dependent hearing loss
- 1 August 2021
- Published by Elsevier in Experimental Gerontology
- Vol. 151, 111429
Association between Cav3 channel upregulation in spiral ganglion neurons and age-dependent hearing loss
- Open Access
- 16 June 2021
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 15
Sensorineural Hearing Loss and Mitochondrial Apoptosis of Cochlear Spiral Ganglion Neurons in Fibroblast Growth Factor 13 Knockout Mice
Deafness is known to occur in more than 400 syndromes and accounts for almost 30% of hereditary hearing loss. The molecular mechanisms underlying such syndromic deafness remain unclear. Furthermore, deafness has been a common feature in patients with three main syndromes, the BÖrjeson-Forssman-Lehmann syndrome, Wildervanck syndrome, and Congenital Generalized Hirsutism, all of which are characterized by loss-of-function mutations in the Fgf13 gene. Whether the pathogenesis of deafness in these syndromes is associated with the Fgf13 mutation is not known. To elucidate its role in auditory function, we generated a mouse line with conditional knockout of the Fgf13 gene in the inner ear (Fgf13 cKO). FGF13 is expressed predominantly in the organ of Corti, spiral ganglion neurons (SGNs), stria vascularis, and the supporting cells. Conditional knockout of the gene in the inner ear led to sensorineural deafness with low amplitude and increased latency of wave I in the auditory brainstem response test but had a normal distortion product otoacoustic emission threshold. Fgf13 deficiency resulted in decreased SGN density from the apical to the basal region without significant morphological changes and those in the number of hair cells. TUNEL and caspase-3 immunocytochemistry assays showed that apoptotic cell death mediated the loss of SGNs. Further detection of apoptotic factors through qRT-PCR suggested the activation of the mitochondrial apoptotic pathway in SGNs. Together, this study reveals a novel role for Fgf13 in auditory function, and indicates that the gene could be a potential candidate for understanding deafness. These findings may provide new perspectives on the molecular mechanisms and novel therapeutic targets for treatment deafness.
- 16 June 2021
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 15
Open AccessSensorineural Hearing Loss and Mitochondrial Apoptosis of Cochlear Spiral Ganglion Neurons in Fibroblast Growth Factor 13 Knockout Mice
Deafness is known to occur in more than 400 syndromes and accounts for almost 30% of hereditary hearing loss. The molecular mechanisms underlying such syndromic deafness remain unclear. Furthermore, deafness has been a common feature in patients with three main syndromes, the BÖrjeson-Forssman-Lehmann syndrome, Wildervanck syndrome, and Congenital Generalized Hirsutism, all of which are characterized by loss-of-function mutations in the Fgf13 gene. Whether the pathogenesis of deafness in these syndromes is associated with the Fgf13 mutation is not known. To elucidate its role in auditory function, we generated a mouse line with conditional knockout of the Fgf13 gene in the inner ear (Fgf13 cKO). FGF13 is expressed predominantly in the organ of Corti, spiral ganglion neurons (SGNs), stria vascularis, and the supporting cells. Conditional knockout of the gene in the inner ear led to sensorineural deafness with low amplitude and increased latency of wave I in the auditory brainstem response test but had a normal distortion product otoacoustic emission threshold. Fgf13 deficiency resulted in decreased SGN density from the apical to the basal region without significant morphological changes and those in the number of hair cells. TUNEL and caspase-3 immunocytochemistry assays showed that apoptotic cell death mediated the loss of SGNs. Further detection of apoptotic factors through qRT-PCR suggested the activation of the mitochondrial apoptotic pathway in SGNs. Together, this study reveals a novel role for Fgf13 in auditory function, and indicates that the gene could be a potential candidate for understanding deafness. These findings may provide new perspectives on the molecular mechanisms and novel therapeutic targets for treatment deafness.
- Open Access
- 4 December 2019
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 12, 296
Transient Receptor Potential Cation Channel Subfamily Vanilloid 4 and 3 in the Inner Ear Protect Hearing in Mice
The transient receptor potential cation channel, vanilloid type (TRPV) 3, is a member of the TRPV subfamily that is expressed predominantly in the skin, hair follicles, and gastrointestinal tract. It is also distributed in the organ of Corti of the inner ear and colocalizes with TRPV1 or TRPV4, but its role in auditory function is unknown. In the present study, we demonstrate that TRPV3 is expressed in inner hair cells (HCs) but mainly in cochlear outer HCs in mice, with expression limited to the cytoplasm and not detected in stereocilia. We compared the number of HCs as well as distortion product otoacoustic emissions (DPOAE) and auditory brainstem response (ABR) thresholds between TRPV3 knockout (V3KO) and wild-type (V3WT) mice and found that although most mutants (72.3%) had normal hearing, a significant proportion (27.7%) showed impaired hearing associated with loss of cochlear HCs. Compensatory upregulation of TRPV4 in HCs prevented HC damage and kanamycin-induced hearing loss and preserved normal auditory function in most of these mice. Thus, TRPV4 and TRPV3 in cochlear HCs protect hearing in mice; moreover, the results suggest some functional redundancy in the functions of TRPV family members. Our findings provide novel insight into the molecular basis of auditory function in mammals that can be applied to the development of strategies to mitigate hearing loss.
- 4 December 2019
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 12, 296
Open AccessTransient Receptor Potential Cation Channel Subfamily Vanilloid 4 and 3 in the Inner Ear Protect Hearing in Mice
The transient receptor potential cation channel, vanilloid type (TRPV) 3, is a member of the TRPV subfamily that is expressed predominantly in the skin, hair follicles, and gastrointestinal tract. It is also distributed in the organ of Corti of the inner ear and colocalizes with TRPV1 or TRPV4, but its role in auditory function is unknown. In the present study, we demonstrate that TRPV3 is expressed in inner hair cells (HCs) but mainly in cochlear outer HCs in mice, with expression limited to the cytoplasm and not detected in stereocilia. We compared the number of HCs as well as distortion product otoacoustic emissions (DPOAE) and auditory brainstem response (ABR) thresholds between TRPV3 knockout (V3KO) and wild-type (V3WT) mice and found that although most mutants (72.3%) had normal hearing, a significant proportion (27.7%) showed impaired hearing associated with loss of cochlear HCs. Compensatory upregulation of TRPV4 in HCs prevented HC damage and kanamycin-induced hearing loss and preserved normal auditory function in most of these mice. Thus, TRPV4 and TRPV3 in cochlear HCs protect hearing in mice; moreover, the results suggest some functional redundancy in the functions of TRPV family members. Our findings provide novel insight into the molecular basis of auditory function in mammals that can be applied to the development of strategies to mitigate hearing loss.